Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors
- Mansoor N. Saleh
- , Steve Sugarman
- , James Murray
- , Joy B. Ostroff
- , Diane Healey
- , Dennie Jones
- , Carol R. Daniel
- , Donna LeBherz
- , Hannah Brewer
- , Nicole Onetto
- , Albert F. LoBuglio
Research output: Contribution to journal › Article › peer-review
173
Citations
(Scopus)